Genomic vitamin D signaling in breast cancer: Insights from animal models and human cells
- 20 April 2010
- journal article
- review article
- Published by Elsevier BV in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 121 (1-2), 362-367
- https://doi.org/10.1016/j.jsbmb.2010.03.061
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Mammary epithelial cell transformation is associated with deregulation of the vitamin D pathwayJournal of Cellular Biochemistry, 2008
- Effect of a Western-Style Diet Fortified with Increased Calcium and Vitamin D on Mammary Gland of C57Bl/6 MiceJournal of Medicinal Food, 2008
- Synchronized Seasonal Variations of Mammographic Breast Density and Plasma 25-Hydroxyvitamin DCancer Epidemiology, Biomarkers & Prevention, 2007
- Potentiation of radiation sensitivity in breast tumor cells by the vitamin D3 analogue, EB 1089, through promotion of autophagy and interference with proliferative recoveryMolecular Cancer Therapeutics, 2006
- Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissuesThe Journal of Steroid Biochemistry and Molecular Biology, 2005
- Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu miceCarcinogenesis: Integrative Cancer Research, 2004
- Altered gene expression profile in the kidney of vitamin D receptor knockout miceJournal of Cellular Biochemistry, 2003
- Role of Mitochondria and Caspases in Vitamin D-mediated Apoptosis of MCF-7 Breast Cancer CellsPublished by Elsevier BV ,2001
- EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitroBritish Journal of Pharmacology, 1998
- Apoptotic Regression of MCF-7 Xenografts in Nude Mice Treated with the Vitamin D3 Analog, EB1089Endocrinology, 1998